How severe is CVE-2023-37395?

CVE-2023-37395 has a CVSS 3.x base score of 2.5, rated low severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.

Is CVE-2023-37395 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-37395?

CVE-2023-37395 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-37395?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2023-37395 have an EU (EUVD) identifier?

Yes. CVE-2023-37395 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41296.

When was CVE-2023-37395 published?

CVE-2023-37395 was published on 2024-12-11 and last updated on 2026-06-17.

CVE-2023-37395

CVE-2023-37395 is a low-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 2.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-327.

Key facts

Severity: Low (CVSS 3.x base score 2.5)
EPSS exploit prediction: 0% (1st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2023-41296
Weakness: CWE-327
Affected product: Ibm Aspera Faspex
Published: 2024-12-11
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to obtain sensitive information due to improper encryption of certain data.

Frequently asked questions

What is CVE-2023-37395?: IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to obtain sensitive information due to improper encryption of certain data.
How severe is CVE-2023-37395?: CVE-2023-37395 has a CVSS 3.x base score of 2.5, rated low severity. It is exploitable over local access with high attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2023-37395 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (1st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-37395?: CVE-2023-37395 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-37395?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-37395 have an EU (EUVD) identifier?: Yes. CVE-2023-37395 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-41296.
When was CVE-2023-37395 published?: CVE-2023-37395 was published on 2024-12-11 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7148632

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-327 (Use of a Broken or Risky Cryptographic Algorithm) vulnerabilities

CVE-2026-50086 — Critical (CVSS 10.0): The Aqara IAM/SSO gateway (gw-builder.aqara.com) exposes bidirectional AES round-trups against the platform's signing…
CVE-2026-21718 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in Copeland XWEB Pro version 1.12.1 and prior, enabling any attackers to…
CVE-2025-54426 — Critical (CVSS 9.9): Polkadot Frontier is an Ethereum and EVM compatibility layer for Polkadot and Substrate. In versions prior to commit…
CVE-2024-51478 — Critical (CVSS 9.9): YesWiki is a wiki system written in PHP. Prior to 4.4.5, the use of a weak cryptographic algorithm and a hard-coded…
CVE-2026-28252 — Critical (CVSS 9.8): A Use of a Broken or Risky Cryptographic Algorithm vulnerability in Trane Tracer SC, Tracer SC+, and Tracer Concierge…
CVE-2025-13476 — Critical (CVSS 9.8): Rakuten Viber Cloak mode in Android v25.7.2.0g and Windows v25.6.0.0–v25.8.1.0 uses a static and predictable TLS…

Browse all CWE-327 (Use of a Broken or Risky Cryptographic Algorithm) vulnerabilities →